Cargando…

S100A8/A9 Enhances Immunomodulatory and Tissue-Repairing Properties of Human Amniotic Mesenchymal Stem Cells in Myocardial Ischemia-Reperfusion Injury

Paracrine factors of human mesenchymal stem cells (hMSCs) have the potential of preventing adverse cardiac remodeling after myocardial infarction (MI). S100A8 and S100A9 are calcium-binding proteins playing essential roles in the regulation of inflammation and fibrous tissue formation, and they migh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Tzu-Jou, Yeh, Yen-Ting, Peng, Fu-Shiang, Li, Ai-Hsien, Wu, Shinn-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541313/ https://www.ncbi.nlm.nih.gov/pubmed/34681835 http://dx.doi.org/10.3390/ijms222011175

Ejemplares similares

Human amniotic membrane mesenchymal stem cells-conditioned medium attenuates myocardial ischemia-reperfusion injury in rats by targeting oxidative stress
por: Mokhtari, Behnaz, et al.
Publicado: (2020)

Phellinus linteus Mycelium Alleviates Myocardial Ischemia-Reperfusion Injury through Autophagic Regulation
por: Su, Hsing-Hui, et al.
Publicado: (2017)

Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells
por: Kang, Jung Won, et al.
Publicado: (2012)

B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells
por: Magatti, Marta, et al.
Publicado: (2020)

Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia–reperfusion injury
por: Chen, Yen-Ta, et al.
Publicado: (2013)

The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits
por: WANG, YAN, et al.
Publicado: (2016)

Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia
por: Kimura, M, et al.
Publicado: (2012)

Role of cytokines in myocardial ischemia and reperfusion
por: Sharma, H. S., et al.
Publicado: (1997)

Platelets in Myocardial Ischemia/Reperfusion Injury
por: Schanze, Nancy, et al.
Publicado: (2022)

Inhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem Cells
por: Zhang, Heng, et al.
Publicado: (2016)

Clec4e-Receptor Signaling in Myocardial Repair After Ischemia-Reperfusion Injury
por: Veltman, Denise, et al.
Publicado: (2021)

Amniotic mesenchymal cells from pre‐eclamptic placentae maintain immunomodulatory features as healthy controls
por: Pianta, Stefano, et al.
Publicado: (2015)

Progesterone prevents epithelial-mesenchymal transition of ovine amniotic epithelial cells and enhances their immunomodulatory properties
por: Canciello, Angelo, et al.
Publicado: (2017)

Unveiling the immunomodulatory shift: Epithelial-mesenchymal transition Alters immune mechanisms of amniotic epithelial cells
por: Di Lollo, Valeria, et al.
Publicado: (2023)

Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats
por: Chua, Sarah, et al.
Publicado: (2014)

Autologous Transplantation of Adipose-Derived Mesenchymal Stem Cells Markedly Reduced Acute Ischemia-Reperfusion Lung Injury in a Rodent Model
por: Sun, Cheuk-Kwan, et al.
Publicado: (2011)

Effects of Endothelin-1 and nitric oxide levels on myocardial ischemia-reperfusion injury
por: Ai, Wenwei, et al.
Publicado: (2022)

Neuroprotective effects of human amniotic fluid stem cells‐derived secretome in an ischemia/reperfusion model
por: Castelli, Vanessa, et al.
Publicado: (2020)

Curcumin attenuates myocardial ischemia–reperfusion injury
por: Liu, Kun, et al.
Publicado: (2017)

Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
por: Schanze, Nancy, et al.
Publicado: (2019)

Platelets, diabetes and myocardial ischemia/reperfusion injury
por: Russo, Isabella, et al.
Publicado: (2017)

The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin
por: Magatti, Marta, et al.
Publicado: (2018)

Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory Reaction
por: Chen, Yen-Ta, et al.
Publicado: (2011)

Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia‐Reperfusion
por: Mofid, Azadeh, et al.
Publicado: (2017)

S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
por: Liao, Wei-Chih, et al.
Publicado: (2023)

Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
por: Xing, Li, et al.
Publicado: (2014)

Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries
por: Zhao, Tianjiao, et al.
Publicado: (2021)

Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury
por: Mao, Chengyu, et al.
Publicado: (2021)

Diabetes Upregulates Oxidative Stress and Downregulates Cardiac Protection to Exacerbate Myocardial Ischemia/Reperfusion Injury in Rats
por: Chien, Chen-Yen, et al.
Publicado: (2020)

Novel application of amino-acid buffered solution for neuroprotection against ischemia/reperfusion injury
por: Hsu, Jiun, et al.
Publicado: (2019)

Muscone ameliorates myocardial ischemia‒reperfusion injury by promoting myocardial glycolysis
por: Gu, Xin, et al.
Publicado: (2023)

Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury
por: Wang, Yi-Hsin, et al.
Publicado: (2018)

Protective Effect of Tetramethylpyrazine on Myocardial Ischemia-Reperfusion Injury
por: Qian, Weidong, et al.
Publicado: (2014)

Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury
por: Singhal, Arun K., et al.
Publicado: (2010)

Effect of trapidil in myocardial ischemia-reperfusion injury in rabbit
por: Liu, MingJie, et al.
Publicado: (2014)

Protective approaches against myocardial ischemia reperfusion injury
por: Li, Xianchi, et al.
Publicado: (2016)

Protective effect of celastrol on myocardial ischemia–reperfusion injury
por: Li, Xiaoyan, et al.
Publicado: (2017)

Long Noncoding RNAs in Myocardial Ischemia-Reperfusion Injury
por: Zhao, Zhuo, et al.
Publicado: (2021)

HIF-1α in myocardial ischemia-reperfusion injury
por: Zheng, Jie, et al.
Publicado: (2021)

Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury
por: Zhao, Wei-kun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0pc7t7v5v83sdi7hhtq5hu5ia3